Evidence map›Paper›PMID 32952386›Full record

ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2020

Radiotherapeutic Care of Patients With Stage IV Lung Cancer with Thoracic Symptoms in the Veterans Health Administration.

Ruchika Gutt, Sheetal Malhotra, Drew Moghanaki, Alice V Cheuk, Lori Hoffman-Hogg, Maria Kelly, Helen Fosmire, George Dawson

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ruchika Guttis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Sheetal Malhotrais a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Drew Moghanakiis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Alice V Cheukis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Lori Hoffman-Hoggis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Maria Kellyis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Helen Fosmireis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
George Dawsonis a Radiation Oncologist at the Washington DC VA Medical Center (VAMC). is an Endocrinologist at The Southeast Permanente Medical Group in Jonesboro, Georgia. is a Radiation Oncologist at the Atlanta VAMC in Georgia. is a Radiation Oncologist at the James J. Peters VAMC in the Bronx, New York, and an Assistant Professor at Mount Sinai School of Medicine. is National Program Manager for Prevention Policy at Veterans Health Administration National Center for Health Promotion and Disease Prevention in Durham, North Carolina. and are Radiation Oncologists at the New Jersey VA Health Care System in East Orange. is Deputy Chief of Staff at the Richard L. Roudebush VAMC in Indianapolis, Indiana.
Veterans Health Administration · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadiotherapy plays an important role in the palliation of lung cancer, which is the second most common cancer diagnosed in the Veterans Health Administration (VHA). The American Society for Radiation Oncology (ASTRO) developed evidenced-based treatment guidelines for the management of patients with metastatic lung cancer.

methodsIn May 2016, an electronic survey of 88 VHA radiation oncologists (ROs) was conducted to assess metastatic lung cancer management. Demographic information was obtained and 2 clinical scenarios were presented to glean opinions on dose/fractionation schemes preferred, preferences for/against concurrent chemotherapy, and use of endobronchial brachytherapy (EBB) and/or yttrium aluminum garnet (YAG) laser technology. Survey results were assessed for concordance with published ASTRO guidelines.

resultsThe survey response rate was 61%, with 93% of the 40 VHA radiation departments represented. Among respondents, 96% were board certified, and 90% held academic appointments. 88% were familiar with ASTRO guidelines. Preferred fractionation schemes were 20 Gy in 5 fractions (69%) and 30 Gy in 10 fractions (22%). The vast majority (98%) did not recommend concurrent chemotherapy for palliation. In the setting of bronchial obstruction with lung collapse, about half (49%) recommended EBB or YAG lung reexpansion before external beam radiotherapy. A minority of respondents use stereotactic body radiotherapy or EBB for palliation.

conclusionMost respondents demonstrated up-to-date knowledge of current evidence-based treatment guidelines. We found no distinction in clinical decisions based on demographic profiles.

Identifiers

PMID32952386
PMCPMC7497879
OpenAlexW3087702105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.